These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1746095)

  • 1. Efficacy and tolerance of norfloxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury.
    Waites KB; Canupp KC; DeVivo MJ
    Urology; 1991 Dec; 38(6):589-96. PubMed ID: 1746095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
    Corrado ML; Grad C; Sabbaj J
    Am J Med; 1987 Jun; 82(6B):70-4. PubMed ID: 3300314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of urinary tract infection following spinal cord injury.
    Waites KB; Canupp KC; DeVivo MJ
    Paraplegia; 1993 Oct; 31(10):645-52. PubMed ID: 8259327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of norfloxacin vs. ciprofloxacin in complicated urinary tract infection.
    Schaeffer AJ; Anderson RU
    Urology; 1992 Nov; 40(5):446-9. PubMed ID: 1441044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice.
    Boerema JB; Willems FT
    Infection; 1990; 18 Suppl 2():S80-8. PubMed ID: 2286467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study.
    Salomon J; Denys P; Merle C; Chartier-Kastler E; Perronne C; Gaillard JL; Bernard L
    J Antimicrob Chemother; 2006 Apr; 57(4):784-8. PubMed ID: 16473921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the efficacy of oral norfloxacin in pyelonephritis and nosocomial urinary tract infection.
    Corrado ML; Roylance PJ; Struble WE; Lancaster MS
    Eur Urol; 1990; 17 Suppl 1():24-9. PubMed ID: 2191866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of norfloxacin and trimethoprim for the treatment of elderly patients with urinary tract infection.
    Ewer TC; Bailey RR; Gilchrist NL; Aitken JM; Sainsbury R
    N Z Med J; 1988 Aug; 101(852):537-9. PubMed ID: 3045717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of NFLX (norfloxacin) in complicated urinary tract infections].
    Murase T; Mitsuya H; Fukatsu H; Yoshida K; Natsume H; Obata K; Ohshima S; Asaka H; Kobayashi M; Okamura K
    Hinyokika Kiyo; 1986 Aug; 32(8):1167-75. PubMed ID: 3788743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infection in acute spinal cord injury.
    Menon EB; Tan ES
    Singapore Med J; 1992 Aug; 33(4):359-61. PubMed ID: 1411664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
    Sapico FL; Lindquist LB; Montgomerie JZ; Jimenez EM; Morrow JW
    Urology; 1980 May; 15(5):457-60. PubMed ID: 6763394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiclinic study of norfloxacin for treatment of urinary tract infections.
    Schaeffer AJ
    Am J Med; 1987 Jun; 82(6B):53-8. PubMed ID: 3300311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of complicated urinary infections with a new drug of unusual efficacy: norfloxacin].
    Fischetti GC; Giovannoni T; Stillitani E; Cristini C; Furbetta A; Lelli A
    Minerva Urol Nefrol; 1985; 37(1):83-6. PubMed ID: 2413557
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
    Fujii R; Meguro H; Arimasu O; Ushijima K; Abe T; Nakazawa S; Sato H; Narita A; Niino K; Ichihashi H
    Jpn J Antibiot; 1990 Jan; 43(1):181-215. PubMed ID: 2190014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
    Cherubin C; Stilwell S
    Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.